Lesson 2
Respiratory Distress Syndrome (RDS)
Surfactant Production:
Initiated by type 2 pneumocytes between 22-26 weeks; peak at 35-36 weeks.
Risks:
Insufficient surfactant leads to RDS, hypoxemia, hypercarbia, mixed acidosis, hemodynamic instability, and death.
Preventive Treatment (Pre-Delivery):
Maternal corticosteroids (e.g., betamethasone) to expedite fetal lung maturity.
Post-Delivery Treatment:
CPAP, mechanical ventilation, and exogenous surfactant.
Monitoring:
Preductal & postductal oxygen saturation to check for pulmonary hypertension and cardiac shunts.
Surfactant and Alveolar Function
Functionality of Surfactant:
Reduces surface tension, preventing alveolar collapse as per Laplace's Law (P = 2T/R).
Surfactant Concentration:
Larger alveoli: lower surfactant concentration.
Smaller alveoli: higher surfactant concentration.
Diagnosis of RDS
Symptoms (Immediate after birth):
Grunting, tachypnea, retractions, nasal flaring.
Blood gas shows hypoxemia, hypercarbia, mixed acidosis.
Complications:
Progressive respiratory failure, hemodynamic instability, death.
Risk Factors for RDS
Low birth weight.
Low gestational age.
Oxygen toxicity.
Endotracheal intubation.
Barotrauma from ventilation.
Maternal diabetes.
Treatment Considerations
Corticosteroids:
Administer to laboring mothers with preterm fetal risk; effects peak at 48 hours.
Lecithin/Sphingomyelin (L/S) Ratio:
L/S ratio > 2 indicates adequate lung development; < 2 suggests increased RDS risk.
Post-Delivery Management:
Start with CPAP, may need mechanical ventilation and surfactant delivery via endotracheal tube.
Anesthetic Considerations
Oxygen Management:
Monitor SpO2; avoid hyperoxia to minimize risk of retinopathy of prematurity (ROP).
Oxygen Saturation Monitoring:
Use preductal (right upper extremity) and postductal monitoring (lower extremity) to assess circulation.
Arterial Lines:
Required for frequent ABG and hemodynamic assessment (preferably preductal).
Ventilation Risks:
Positive pressure ventilation increases pneumothorax risk.